Cyclerion Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TYNDALL CAPITAL PARTNERS L P | 05/15/2025 | 164.78 K | $411.94 M | 0.00% | 6.45% |
| SIREN, L.L.C. | 05/23/2025 | 116.16 K | $290.39 K | 0.00% | 4.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 31.60 K | $78.09 K | -0.68% | 1.24% |
| VANGUARD GROUP INC | 05/09/2025 | 23.49 K | $58.02 K | 0.00% | 0.92% |
| BLACKROCK, INC. | 05/02/2025 | 16.80 K | $41.99 K | 0.00% | 0.66% |
| UBS GROUP AG | 05/13/2025 | 13.00 K | $32.50 K | 34.49% | 0.51% |
| FMR LLC | 05/12/2025 | 4.94 K | $12.20 K | 4.22% | 0.19% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.05 K | $2.64 K | -56.82% | 0.04% |
| MORGAN STANLEY | 05/15/2025 | 649 | $1.62 K | 0.00% | 0.03% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 540 | $1.33 K | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 130 | $325 | 0.00% | 0.01% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 100 | $250 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 05/15/2025 | 100 | $250 | 0.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 04/09/2025 | 20 | $50 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 19 | $48 | 0.00% | 0.00% |
| 05/02/2025 | 11 | $28 | 0.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 5 | $12 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 1 | $3 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclerion Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Cyclerion Therapeutics, Inc.. The most heavily invested institutionals were:
ZRC WEALTH MANAGEMENT, LLC: 0
TYNDALL CAPITAL PARTNERS L P: 164,777
Siren, L.L.C.: 116,155
GEODE CAPITAL MANAGEMENT, LLC: 31,603
VANGUARD GROUP INC: 23,490
BlackRock, Inc.: 16,797
14.61% of Cyclerion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 818.57 K shares in the last 24 months. This purchase volume represents approximately $2.64 M in transactions.